Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,299 | -109,089 | -44,187 | -168,099 | -129,272 |
| Depreciation Amortization | 366 | 300 | 231 | 2,959 | 2,530 |
| Accounts payable and accrued liabilities | 1,559 | -7,897 | -6,531 | -1,235 | -5,881 |
| Other Working Capital | 778 | -3,722 | -7,921 | -5,379 | -10,535 |
| Other Operating Activity | 13,444 | 17,858 | 11,500 | 18,109 | 18,705 |
| Operating Cash Flow | $-153,152 | $-102,550 | $-46,908 | $-153,645 | $-124,453 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -44,262 | -34,684 | -16,687 | -121,176 | -94,712 |
| PPE Investments | -647 | -480 | -230 | -3,067 | -2,548 |
| Purchase Of Investment | 100,195 | 77,629 | 42,150 | 208,291 | 162,466 |
| Sale Of Investment | 1,829 | 1,829 | 1,829 | 3,154 | 2,759 |
| Investing Cash Flow | $57,115 | $44,294 | $27,062 | $87,202 | $67,965 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 54,175 | 53,721 | 28,815 | 37,390 | 187 |
| Financing Cash Flow | $54,175 | $53,721 | $28,815 | $37,390 | $187 |
| Beginning Cash Position | 174,466 | 174,466 | 174,466 | 203,519 | 203,519 |
| End Cash Position | 132,604 | 169,931 | 183,435 | 174,466 | 147,218 |
| Net Cash Flow | $-41,862 | $-4,535 | $8,969 | $-29,053 | $-56,301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -153,152 | -102,550 | -46,908 | -153,645 | -124,453 |
| Capital Expenditure | -647 | -480 | -230 | -3,067 | -2,548 |
| Free Cash Flow | -153,799 | -103,030 | -47,138 | -156,712 | -127,001 |